The glucose metabolic rate of the human brain can be measured with labeled deoxyglucose, using positron emission tomography, provided certain condi tions are fulfilled. The original method assumed irrevers ible trapping of deoxyglucose metabolites in brain during the experimental period, and it further requires that a conversion factor between deoxyglucose and glucose, the "lumped constant," be known for the brain regions of interest. We examined the assumption of irreversible trapping of fluorodeoxyglucose metabolites in brain of four patients in 365 normal and 4 recently infarcted re gions. The average net, steady-state rate of fluorode oxyglucose (KD) accumulation in normal regions of the four patients was 0.025 ml g-I min -I . We also examined the variability of the lumped constant. We first confirmed that methylglucose is not phosphorylated in the human brain. We then estimated the lumped constant from the regional distribution of labeled methylglucose in brain. The average (virtual) volume of distribution of labeled methylglucose in the normal regions was 0.46 ml g-I and was the same in both gray and white matter structures. The average brain glucose content corresponding to this value was 1.3 f-lmol g-I , assuming a Michaelis constant (Kt) of 3.7 mM for glucose transport across the blood brain barrier. The lumped constant varied insignificantly between 0.4 and 0.5 in most regions, with an overall av-
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Since the original work of Sokoloff et al. (1977) , regional measurements of the glucose phosphory lation rate in brain have been possible with suitably labeled 2-deoxyglucose , and have been extended to humans (Phelps et aI ., 1979; Reivich et aI., 1979) . The basis of the method is the determination of the steady-state rate of 2-deoxyglucose phosphoryla tion by the hexokinase reaction, the first step in glycolysis. The net rate of 2-deoxyglucose phos phorylation is translated into the net rate of glucose phosphorylation by division with an isotope correc tion fa ctor, the lumped constant , which equals the ratio between the net rates in the steady state .
Two requirements underlie the method: First , the loss of phosphorylated deoxyglucose must be insig nificant during the experimental period , and second, the lumped constant must be known. The lumped constant incorporates the diffe rent affinities of deoxyglucose and glucose fo r transport across the blood-brain barrier and phosphorylation by hexokinase . The affinity of deoxyglucose fo r trans port is higher than that of glucose , whereas the af finity of deoxyglucose fo r phosphorylation is lower than that of glucose .
The apparent affinities are subject to competition between deoxyglucose and glucose. Hence, the rel ative affinities must vary if the glucose concentra tion varies in the space between the transport and the hexokinase reactions. Direct measurements of regional brain glucose concentrations and indirect measurements by means of labeled methylglucose in the rat brain revealed only little regional variation under normal conditions (Gjedde and Diemer, 1983) . Under normal circumstances, therefore , the lumped constant does not appear to vary regionally. However, in humans, the regional brain glucose concentrations are unknown.
The deoxyglucose-6-phosphate was originally as sumed to be quantitatively trapped in the tissue be cause the rat brain has little or no deoxyglucose phosphatase activity (Anchors et aI ., 1977) . How ever, Huang and Ve ech (1982) reported significant glucose phosphatase activity in brain. From the above , it appears that the available evidence re mains inconclusive with regard to both the regional variation of the lumped constant and the signifi cance of the regional phosphatase activity.
The rate constants of glucose and deoxyglucose transport and phosphorylation are important for the proper assessment of the lumped constant , rather than for the net rate of deoxyglucose accumulation.
However, the rate constants, and particularly, k2 for deoxyglucose , cannot be accurately estimated in a kinetic study because of uncertainties about the earliest values of tracer accumulation. The present study attempts to circumvent this difficulty by es timating the rate constants from steady-state vol umes of distribution and the steady-state rate of deoxyglucose accumulation. The steady-state ap proach suffers from another difficulty, that of ob taining true steady-state values in a study of limited duration. However, even if steady-state require ments cannot be completely fulfilled, the volumes of distribution can be expected to be subject to less uncertainty than the rate constants.
J Cereb Blood Flow Metabol, Vol. 5, No.2, 1985 In the fo llowing , we attempt to describe the de oxyglucose method in terms of measurable quanti ties and known constants. We examine the three questions posed above : (a) Is there significant early loss of fl uorodeoxyglucose metabolites in the human brain? (b) Is methylglucose phosphorylated and therefore not a good index of free glucose in brain tissue? (c) Does the lumped constant vary re gionally? We present evidence that the require ments of the deoxyglucose method are fulfilled in the normal human brain, and we show how the lumped constant may be estimated regionally in pathological tissue , using methylglucose . The first question has been examined previously by Phelps et al . (1979) and Huang et al . (1980) in normal hu mans and by Hawkins et al . (1981) in stroke pa tients.
METHODS

Theory
In the present study, we used the uptake of 3-0-r II C]methyl-D-glucose and IX F-substituted 2-fluoro-2-deoxY-D-glucose, as functions of time, to calculate three variables: the net rate of fluorodeoxyglucose metabolite accumulation, the distribution volume of unphosphory lated fluorodeoxyglucose (fluorodeoxyglucose exchange able with blood plasma), and the steady-state volume of distribution of methylglucose in brain. We represent these variables by the symbols K D , V?, and Ve'
The following symbols apply: M for mass, e.g., amount or content of isotope per unit weight of brain (unit, mol g-I or dpm g -I ); V for volume of distribution, e.g., dis tribution volume of glucose per unit weight of brain (unit, ml g-I ); C for concentration, e.g., glucose concentration in plasma (unit, mmol L -l or dpm ml-I ); and K for clear ance, e,g., net clearance of glucose into brain (unit, ml g-I min -I ). The tracer flux equals the product of tracer clearance and tracer concentration. The superscripts G, 0, and M refer to glucose, deoxy-or fluorodeoxyglucose, and methylglucose, respectively.
Fluorodeoxyglucose accumulation. Question (a): Is the trapping of fluorodeoxyglucose metabolites complete? According to the original derivation by Sokoloff et al. (1977) , the net rate of irreversible trapping of labeled fluo rodeoxyglucose-6-phosphate and other metabolites of fluorodeoxyglucose equals
where K D is the net, steady-state rate of accumulation of fluorodeoxyglucose metabolites; M hl is the accumulated metabolic product; M � is the remaining un metabolized tracer, exchangeable with blood plasma; C\? is the tracer concentration in arterial plasma as a function of time; and K? is a transfer coefficient ("clearance ") representing the unidirectional tracer flux from the arterial plasma to the brain tissue.
In the steady state (at infinite time if the tracer con centration continues to fall slowly in plasma), the equa-tion can be simplified to exclude entities that cannot be measured directly (M� and M\?) (Gjedde, 1982) by ex pressing M\? as the product of the steady-state volume of distribution v9, equal to the ratio K?/(k� + k�), and c�, arterial tracer concentration:
where MD(T) is the total concentration of label in the tissue and k� and k� are rate constants that describe ef flux from the brain tissue to the blood plasma and phos phorylation by hexokinase, respectively. Equation 2 can be further simplified by exclusion of the independent variable C� through division (Gjedde, 1982) :
where VD(T) and V� are apparent volumes of distribution. VD(T) is the total apparent volume of distribution as a function of time, which equals the MD(T)/C?t(T) ratio. V� is the apparent volume of the precursor pool (including both vascular and tissue compartments) and equals the combination [K? k�/(k� + k�) 2 J given in Eq. 2. The de rived term 8D(T), "theta of T," is calculated as the ratio between the time-concentration integral and the blood concentration, i.e., rr;C�(t)dtIC�(T). Phelps et al. (1979) and Huang et al. (1980) 
Equation 4 expresses the general principle that an irre versible step in the accumulation of a tracer leads to a linear relationship between the total amount accumulated and the time-concentration integral in the bloodstream (Patlak et aI., 1983 
where V? is the virtual volume of distribution of the un phosphorylated tracer and v9 is the virtual volume of distribution of native glucose.
The phosphorylation ratio (7T) is the ratio between the glucose and fluorodeoxyglucose Km values for hexoki nase. In human brain, it is unknown, so we are forced to assume that it equals that of rat, ranging from 0.25 (Crane et aI., 1980) to 0.37 (Cunningham and Cremer, 1981 
We can reduce Eq. 7 to a combination of measurable quantities, by substituting Eqs. 5 and 8:
The quantity M2 is the glucose content in brain tissue. It is not known in humans. However, as discussed previ ously (Gjedde and Diemer, 1983) , it affects the distribu tion of methylglucose,
where KY is the Michaelis const , ant for glucose transport across the blood-brain barrier, c2 is the glucose concen tration in brain water, and Vd is the brain water volume (actual distribution space of hexoses in brain). Hence, M2 = Ve c� -KY (Vd -Ve) (11) in which both variables, c� and Ve' are directly measur able and Vd and KY are supplied constants.
In the following, we assume that Vd, the brain water volume, is 0.78 ml g-I and that KY, the Michaelis con stant, is 3.7 mM. In that case, Eq. 9 reduces to
where only measurable variables are included. Three constants are required to perform the calcula tion, including the brain water volume Vd, the phosphor ylation ratio 7T, and the K? of glucose transport. In the present study, these constants were chosen on the basis of the literature, corresponding to a whole-brain lumped constant of 0.42 (Phelps et aI., 1979) . The K? of 3.7 mM represents 70% of the average whole-blood glucose con centration of 5.3 mM in the present study. Therefore, it represents the same fraction of the glucose concentration found in rat (Kt averages 7 mM and the plasma glucose averages 10 mM). If the constants are later shown to be somewhat different, all lumped constants of the brain will shift in the same direction, but their mutual relationship will not change.
Transfer constants. The transfer constants K?, k�, and k� can be estimated by fitting Eq. I to the actual uptake curve by solving the linked differential equations 16a and 16b shown below. Alternatively, they can be calculated from the solutions of the steady-state expressions of the apparent volumes of distribution shown in Ta ble 1:
Ve -V?
In the present study, the latter procedure was used be cause it permits calculation of the transfer constants from steady-state expressions of measurable quantities.
Positron emission tomography
Patients. The study was performed on four stroke pa tients, aged 54-73 years. Informed consent to the study was obtained in each case. A carotid or cerebral artery occlusion occurred 10-52 days prior to their positron emission tomography examination. The clinical manifes tations are summarized in Ta ble 2. Each patient was in vestigated twice, once with 18F-substituted tluorodeoxy glucose, and the following day with [IIC]methylglucose. During the interval, no appreciable change of clinical status occurred in the patients. The patients were com fortably placed on a reclining chair in a room with low ambient light and noise, eyes closed and ears unplugged. Approximately 15 min before starting the examination, short catheters were inserted into an antecubital vein for injection of tracers and into a contralateral hand vein for blood "sampling" ad modum Phelps et al. (1979) in a thermostatically controlled water bath at 44°C.
Tracers and scanning procedure. (Kloster et aI., 1981; Laufer and Kloster, 1982) . Between 8 and 14 mCi methylglucose was prepared in sterile solution after chromatographic purification and sterile filtration. The 2-[18F ]fluoro-2-deoxY-D-glucose was prepared by the method of Ido et al. (1977) . using a remote-control syn thesis system (Barrio et aI., 1981; Fowler et aI., \981) . Recording began when each patient received a rapid intravenous bolus injection of �5 mCi fluorodeoxy-or methylglucose in 5 ml sterile, pyrogen-free normal saline. Seven equally spaced and parallel planes, centered from the canthomeatal line to 81 mm above, were simulta neously scanned for 40 min at consecutive intervals grad ually increasing from 1 to 5 min, using a four-ring positron camera (Scanditronix PC 384) with a spatial resolution of approximately 8 mm full width at half-maximum in 11-mm slices . This procedure yielded dynamic information about tracer accumulation in vir tually all major structures of the brain. Data from the tomographic device and from a sample changer used for plasma counting, as well as plasma glucose values deter mined in duplicates by a standard enzymatic method, were stored in the memory of a VAX 111780 (Digital) computer for later processing.
Image processing. The spatial activity distribution in the scanned planes was reconstructed employing an edge finding algorithm to determine the skull contour for at tenuation correction , a decon volution for subtraction of scattered radiation (Bergstrom et al., 1983) , and a filtered back projection algorithm, resulting in a 128 x 128 matrix that was displayed as an interpolated 256 x 256-pixel image. Activities measured in tissue and in plasma were corrected for decay and ad justed by cross-calibration of the respective counters. On each tomographic image, relevant anatomic struc tures were marked by regions of interest using an inter active computer-assisted procedure . At first, the infarct was identified in an x-ray com puter tomogram and the corresponding areas marked on the positron emission tomograms. Then regions com prising morphologically intact tissue were outlined. The lateral cortical gray matter was schematically divided into nine regions in each cerebral hemisphere, each "wedge" representing an angular step of 20°. Hippocampus, cin gulate, and visual cortices were separately identified, as were subcortical gray, white, and mixed matter struc tures.
Calculations and nonlinear regression
Three variables, K D , Ve, and V�, were estimated by least-squares, nonlinear computer optimization. The dif ferential equations below were solved by fitting a sum of four exponentials to the arterial concentration measure ments:
dt TM
where TD and TM are the time constants of fluorodeoxy and methylglucose approach to equilibrium, equal to the mean transit times of the tracers through their respective apparent volumes of distribution. The total radioactivity in the regions of brains injected with labeled fluorode oxyglucose was M D (t) = M�(t) + MgU) , and the total radioactivity from labeled methylglucose was MM(t) . For t = 0, all the functions were zero. From the value of Ve and the blood glucose concentra tion Ca, the brain glucose content M2 was calculated ac cording to Eq. II. Using M2 and the values of Ve and V?, the volume V� was calculated from Eq. 5 and the lumped constant from Eq. 9. Finally, the glucose phos-phorylation rate was computed according to
Using KD, Ve, and V?, the three transfer constants K?, k�, and k� were calculated from the steady-state equa tions 13-15.
In summary, three variables were determined: the net rate of accumulation of fluorodeoxyglucose metabolites (KD), the apparent steady-state volume of distribution of fluorodeoxyglucose (V?), and the corresponding volume of distribution of methylglucose (Ve). The conversion factor (lumped constant) between fluorodeoxyglucose and glucose phosphorylation was calculated from esti mates of the brain glucose content on the basis of the methylglucose distribution and the assumptions stated above.
RESULTS
Fluorodeoxyglucose accumulation
A repres entative plot of the uptake of fluoro deoxyglucose in the visual cortex of one patient (MG) is shown in Fig. 1 (left) . In Fig. 1 (right (range 0-60 min); ordinates, normalized radioactivity in re gion, equal to apparent volume of distribution (range 0-2 ml 9-'), as shown in Fig. 1 (right) . Note horizontal approach of methylglucose and linear rise of fluorodeoxyglucose distri bution.
blood curve). The term V� represents a kinetic volume and has no physical meaning. The term V�' signifies the experience that steady-state kinetic volumes are difficult to determine within definite periods of time because tracer concentrations con tinue to fall in blood. In the present study, the steady-state volumes v9 and Ve were actually de termined kinetically, as expressed in Eqs. 16 and 17. In turn, the rate constants were determined from the steady-state Eqs. 13-15, using information from both runs, i.e., the fluorodeoxyglucose and methylglucose runs. Table 3 . The regional averages of KD varied from 0.014 to 0.032. They were inversely related to the regional averages of v9, ranging from 0.31 to 0.42, thus indicating that the virtual volume of the substrate pool declined when the net removal of sub strate increased .
The accumulation of fluorodeoxyglucose as a function of time is also shown in Fig. 3a as a pseudo-color representation of the measured radio activity. The images record the times "0," 1.9,3.8, 7.2, 11.2, 15.6, 21.5, 27.4, and 36.3 min. Initially, the radioactivity was distributed in a pattern remi niscent of blood flow, and the pattern persisted to the end. The infarcted area remained clearly out lined at the position of 4 o'clock .
Methylglucose accumulation
The accumulation of labeled methylglucose is shown in the lower curves in Fig. 2 , in the 16 cor tical regions, including 1 "pathological " region, of tomograph plane 4 of the brain of patient MG. With the exception of the abnormal region, methylglu cose reached a constant volume of distribution close to 0.5 ml g-I in all regions (including gray and white matter structures) within � 10 min (real time). (Fig. 4) , it becomes obvious that the value of Ve did not vary with KD. Hence, brain glu cose content is independent of the phosphorylation rate prevailing in individual regions, and glucose transport must be positively adjusted to glucose phosphorylation. The accumulation of methylglucose in patient MG (tomograph plane 4) is shown in pseudo-color representation in Fig. 3b . As with panel a, the im ages represent times of "0," 1.9, 3.8, 7.2, 11.2, 15.6, 21.5, 27.4, and 36.3 min. Initially, the pattern of distribution of radioactivity was that of blood flow and fluorodeoxyglucose, but later the regional differences disappeared as an illustration of the nu merical finding that the steady-state methylglucose distribution in the infarcted area (0.40; Ta ble 6) was close to the average for the normal regions in this patient (0.44; Ta ble 3).
Lumped constant
The lumped constant was derived from the esti mated tissue glucose concentrations, assuming a (Table 4 ) . In gray matter re gions, the lumped constant varied between 0.36 and 0.55 (with one exception) , whereas the average lumped constant of white matter regions was 0.45 (using a water content of 0.70 ml g -I in white matter).
The lumped constant was the basis for the cal culation of actual glucose phosphorylation rates from the rates of fluorodeoxyglucose phosphoryla tion (Eq. 18) , as shown in Ta ble 4. In gray matter regions, the glucose phosphorylation varied from 19 /-Lmol 100 g-I min -I in the occipital cortex of the right hemisphere to 46 /-Lmol 100 g -1 min -1 in the lentiform nucleus. The cortical glucose metabolic rates declined in the frontal-occipital direction, being close to 40 /-Lmol 100 g-I min -I in the frontal regions and <30 /-Lmol 100 g -1 min -1 in the occipital regions. The average white matter phosphorylation was 16 /-Lmol 100 g -1 min -I. For reasons elaborated in Discussion, it is likely that the calculated phos phorylation velocities represent �90% of the "true " velocities.
When the lumped constant is inversely related to the fluorodeoxyglucose phosphorylation, it must be even more strongly in inverse proportion to the rate
of glucose phosphorylation. Figure 5 illustrates the hyperbolic relationship between lumped constants and metabolic rates. At very low metabolic rates, the lumped constant exceeded unity; at very high metabolic rates, it averaged 0.30.
Transfer constants
The transfer constants K�, k�, and k� were cal culated on the basis of the average volumes defined in Ta ble 1. The averages of the three constants are listed for gray and white matter regions in Ta ble 5.
The values of K� in gray matter regions were twice as high as those in white matter regions, and their ratio corresponded to the ratio between the glucose phosphorylation rates. In the gray matter regions, the values of K� varied between 0.08 and 0.14 ml g-I min-I.
The relationship between the regional averages of the steady-state (KD) and initial (K�) rates of glu cose transfer is shown in Fig. 6 for the regions listed in Ta bles 5 and 6. According to the method of cal culating KD and K� in the present study, these con stants are independent estimates of hexose trans port and phosphorylation, respectively. The linear relationship confirms the coupling between trans port and metabolism of glucose that ensures very little variation of glucose content between the re gions.
"Pathological" (infarcted) regions
In one patient (WR) , the infarct could not be iden tified with certainty in the positron emission to mograms. In the remaining three patients, infarcts were identified in tomograph plane 5, and , in one patient (MG), also in tomograph plane 4 (Table 6 ) . Hippocampus (n = 14) Lentiform n. (n = 5) Insula (n = 9) Cerebellum (n = 14)
Left hemisphere cortical regions
Glucose content (fLmol g-I )
1. I ± 0. 
Right hemisphere cortical regions
Cortex
1. 5 ± 0.4 Cortex 8 (n = 14)
1.I ± 0. 3 Cortex 9 (n = 6) 0. 9 ± 0. 2 Cingulate (n = 6) 1. 6 ± 0. 5
White matter regions All (n = 18)
All regions (n = 365)
Values are means ± SO.
1. 4 ± 0. 9
1. 3 ± 0. 4
The four infarcted areas were characterized by low rates of fluorodeoxyglucose phosphorylation and low glucose consumption rates (from 2.1 to 17.5 J.Lmol 100 g-l min-I). In two infarcted areas (patients WW and MG, plane 4), methylglucose distribution and glucose contents were close to normal, and lumped con stants were therefore within the normal range. In the remaining infarcts (patients MG, plane 5, and HM), methylglucose distribution and glucose con tents were low, and lumped constants therefore were in excess of unity. On the basis of these ob servations, we identified two infarct types, a trans portlblood flow-limited type with low glucose con tent and a phosphorylation-limited type with normal glucose content. same as that of other enzyme reactions. For an ir reversible reaction, the rate equals the ratio be tween the accumulated product and the time inte gral of the specific substrate activity. This relation ship also underlies the deoxyglucose model, except for the fact that the time integral of the specific activity of the precursor pool cannot be directly as sessed in brain. Instead, the model makes use of the time integral of the substrate concentration in arterial plasma and therefore includes a correction term for the delay imposed by the blood-brain bar rier. This correction corrects not only for delay but also for dispersion and amplitude of response in the tissue precursor pool. The correction term requires knowledge of the rate constants K), k2' and k3' al though the effect of errors in the rate constants on the calculated net rate of deoxyglucose accumula tion is minimized when experiments are run for a sufficiently long time .
It deserves repetition at this point that the rate other hand, suffers from the difficulty of obtaining truly steady-state values in a study of limited du ration. However, even if steady-state requirements cannot be completely fulfilled, the volumes of dis tribution are less subject to error than the rate con stants themselves. Of course, if tracer concentra tions were kept constant in the bloodstream, no compromise would be necessary (Kato et aI., 1984) . Thus, no transfer constants (Kl, k2' or k3) were directly measured in the present study. Instead, re gional glucose phosphorylation rates were calcu lated on the basis of steady-state values of distri bution volumes and fluorodeoxyglucose clearance and three constants, 'IT, Vd, and Ky. Of these, two constants were not known for human brain and in stead were inferred from rat brain in which the values are known (7T and KY). The water volume of brain Vd was assumed to be 0.78 ml g-I for normal gray matter and infarcted brain and 0.70 ml g-I for white matter.
Fluorodeoxyglucose accumulation
Our anser to Question (a) is negative: We discov ered no loss of fluorodeoxyglucose metabolites during the study. The accumulation of labeled fluo rodeoxyglucose metabolites was linear after � 10 min (real time) and continued to rise linearly for the duration of the experiment (40 min, real time). Before 1975 , the brain was believed to possess no detectable glucose-6-phosphatase (Plum et aI. , 1976) . Then, in 1975 , Anchors and Karnovsky gave evidence of phosphatase in rat brain, but the mag nitude relative to glucose metabolism was not de termined. In 1977 , Anchors et al. gave further evi dence that the phosphatase acted primarily as a hy drolase and therefore contributed little to the phosphorylation of glucose. Finally, in 1982 , Huang and Veech calculated the dephosphorylation of glu cose to represent �30% of the phosphorylation, suggesting that only two-thirds of the phosphory lated glucose continued down the glycolytic path. Whereas there is little doubt that the brain pos sesses glucose-6-phosphatase , the latter study, un fo rtunately, did not give a definitive answer to the question of the magnitude of the phosphatase ac tivity relative to the rate of phosphorylation of deoxyglucose (see below).
The net, steady-state rate of deoxyglucose-6-phosphate accumulation is zero in the presence of significant phosphatase activity, and must yield a time-dependent lumped constant that eventually reaches zero. Since no creditable studies indicate a lumped constant of zero within the first hour of in jection of labeled deoxyglucose , the question re mains of how soon steady-state deoxyglucose phos phorylation-dephosphorylation is established.
The original fo rmulation of the lumped constant by Sokoloff et al. (1977) took into account the hy drolysis of glucose-6-phosphate (but not of deoxy glucose-6-phosphate). The present article (Eq. 6) assumes that the phosphorylation of both com pounds is irreversible. Equation 6, to some extent , is less sensitive to the influence of hydrolysis be cause the effe cts on the two compounds tend to cancel. However, they do not cancel completely. (Theoretically, the net extraction fraction of deoxy glucose tends to zero, while the net extraction fraction of glucose declines only to its true steady state value.)
The actual magnitude of the phosphatase activity can be estimated in various ways. First , the steady state ratio between deoxyglucose-6-phosphate and deoxyglucose in brain is close to 10 (Sacks et aI. , 1983; Gj edde, 1984) , indicating that the kWk� ratio is � 10 [as first suggested on the basis of "kinetic, " i. e. non-steady-state measurements, by Phelps et (1979) and Huang et al. (1980) ]. This ratio places the half-life of deoxyglucose-6-phosphate in brain at -25 min. The steady-state volume of distribution of deoxyglucose and its metabolites in brain is -10 ml g-I (Lassen and Gj edde, 1983) . This places the half-life at -45 min. Hawkins and Miller (1978) de termined the half-life to be -20 min. However, none of the studies addressed the significance of the half lives . First, hydrolysis does not equal loss from brain. The isotope must actually have left the brain tissue before the phosphatase activity matters to the calculation of glucose metabolic rate . Second, the phosphorylation of deoxyglucose is so compara tively slow that the full effect of hydrolysis is not fe lt immediately upon introduction of the isotope. The fo llowing fo rmula provides a rough estimate of the significance of dephosphorylation for values of T that are not too large (Gjedde , 1982) :
KD ( was taken from Phelps et al . (1979) . As expected, it is -10% of the value of k9 estimated here. In conclusion, we can state that the net rate of fo r mation of fluorodeoxyglucose metabolites mea sured in this study is -90% of the rate that would have been observed in the absence of brain phos phatase activity. Huang and Veech (1982) calculated the dephos phorylation of glucose-6-phosphate as the differ ence between the calculated rates of phosphoryla tion of glucose labeled with 3H or 14C in different positions . The rates were calculated at < I min after intracarotid injection of the tracers as the ratio be tween the accumulated metabolite and the specific activity of the substrate pool at that time divided by the duration of the experiment . This is a steady or near-steady-state expression that requires con stant specific activity of the substrate pool during the accumulation of metabolites. However, the mean transit time through the glucose pool of rat brain is much longer than 1 min (close to 3-5 min) , indicating that steady state was absent . In that case, the calculation of the rates of phosphorylation re quires integration of the specific activity of the sub strate pool .
Since the actual magnitude of the dephosphory lation of glucose is still in doubt, it seems reason able to propose that it is similar to that of tluorodeoxyglucose. Anchors and Karnovsky (1975) and Hawkins and Miller (1978) reported that the glucose affinity for glucose-6-phosphatase was a factor of -1.4 greater than the affinity of deoxyglucose, whereas the glucose affinity for hexokinase is about three times that of deoxyglucose. Thus, the k9lk¥ ratio must be close to twice the k9lk2 ratio, or -20.
The ratio between the true glycolytic rate and the rate of phosphorylation of glucose can be estimated from a simple steady-state relationship ,
where Me; and Mg are the brain contents of glucose and glucose-6-phosphate, respectively. With a glu cose concentration of 2-3 f.Lmol g -I in the rat brain, a glucose-6-phosphate concentration of 0.1 f.Lmol g-I (Siesjo, 1978) , and a k9lk¥ ratio of 20, the true glycolytic rate exceeds 99. 5% of the phosphoryla tion rate (as also indicated by the low glucose-6-phosphate concentration) . Thus, there is no reason to suspect any significant dephosphorylation of glu cose, and the calculated metabolic rates are -90% of the true glycolytic rate because of the 10% loss of phosphorylated tluorodeoxyglucose.
Methylglucose accumulation
Except in certain abnormal brain regions, radio active methylglucose came to a "secular" equilib rium between brain and blood (indicating that the blood concentration continued to fall monoexpo nentially but the ratio between brain and blood re mained constant) within -10 min (real time) . After that time , there was no further change of the ap parent volume of distribution . The corresponding steady-state volume of distribution averaged 0.46 ml g -I, a value less than the water volume of brain in which the hexoses physically distribute. The reason for the lower virtual volume of distribution of methylglucose is the lower glucose concentration of brain water compared with plasma water. Anchors et al . (1977) showed that methylglucose is not phosphorylated in cultured cells of nervous tissue origin. Additional indirect evidence supports their finding . The absolutely uniform distribution of methylglucose (Sokoloff et al ., 1977 ; Pappius et al ., 1979 ; Diemer and Siemkowicz, 1980 ; this study), the time independence of the apparent volume of distribution (Gjedde, 1982 ;  this study), the obser vation that the apparent volume of distribution is lower than the physical volume (Gjedde and Diemer, 1983 ; this study) , and the observation that the apparent volume of distribution of unphosphor ylated deoxyglucose equals the apparent volume of distribution of methylglucose (Gjedde , 1984) are strong arguments against detectable phosphoryla tion of methylglucose in brain in the present study. The observations do not rule out a rapidly over turning futile cycle of phosphorylation and dephos phorylation, but such a cycle would not be mea surable and would not affe ct the conclusions drawn from the distribution of methylglucose. Gatley et al . (1984) recently published evidence in favor of significant phosphorylation of tracer methylglucose in heart muscle . The explanation may be the presence in heart muscle, but not in brain tissue , of a special type of hexokinase that phosphorylates methylglucose. Thus, our answer to Question (b) is negative : Methylglucose is not phos phorylated in the human brain.
The steady-state volume of distribution of meth ylglucose reflects the relationship between perme abilities of the blood-brain barrier in the directions from blood to brain and from brain to blood. An apparent volume of distribution that is lower than the physical volume of distribution reflects a per meability of the blood -brain barrier in the direction out of brain exceeding that in the opposite direc tion. In fac ilitated diffusion, the apparent perme ability is a function of the prevailing concentration of substrate . Therefore , the high permeability of the blood-brain barrier in the direction out of brain re flects the lower glucose in brain water when com pared with that in plasma water. If the affinity of transport by facilitated diffusion is known (and in the present study it was set to 3.7 mM), the glucose content of brain can be calculated from the steady state distribution of methylglucose, provided meth ylglucose is not metabolized in brain.
The calculation of brain glucose content fr om methylglucose distribution is based on the assump tion that hexose transport across the blood-brain barrier is symmetrical , that methylglucose is pas sively distributed, and that the transport affinity is the same everywhere in brain (Gjedde and Diemer, 1983) .
The assumptions of symmetry and transport af finity have never been examined in humans , and were based on inferences from rat brain. When human studies of unidirectional glucose transfer rates become possible at diffe rent glucose levels in plasma in the same subject, both assumptions come within experimental reach. Confirmation of these basic assumptions is pressing because all quantita tive aspects of the deoxyglucose method in humans depend thereon, as will be explained below.
The overall impression was one of a very homo geneous distribution of methylglucose in all regions of the brain, close to 0. 5 ml g-I everywhere . The constancy of methylglucose distribution means that J Cereb Blood Floll' Metabol, Vo l. 5, No , 2, 1985 the glucose content IS maintained within very narrow limits.
Lumped constant
The answer to Question (c) is al so negative: The lumped constant was uniform between subjects and within the major subdivisions of the brain (e.g., gray and white matter) . This conclusion is inti mately associated with the method of estimating brain glucose content and is subject to the same uncertainties. The lumped constant did vary as a function of the glucose phosphorylation rate: the higher the phosphorylation rate, the lower the lumped constant .
The lumped constant is a conversion term and therefore essential to the quantification of glucose phosphorylation. In theory, deoxyglucose accumu lation can change when glucose phosphorylation changes, but it can also vary if the lumped constant varies. The lumped constant in turn varies as a function of the distribution ratio (Ll). The distribu tion ratio changes when the rate of phosphorylation and the rate of efflux of glucose and deoxyglucose from brain are affected unequally.
The present method of estimating the lumped constant depends on a particular model of blood brain glucose transfer. It differs from the original, model-independent determination of the lumped constant in rat brain (Sokoloff et aI ., 1977) in which the net extraction fractions of glucose and deoxy glucose were compared in the steady state. A model-independent measurement of the lumped constant in human brain has not been made (Phelps et aI ., 1979) , but there cannot be much doubt of its magnitude since the whole-brain glucose consump tion rate is well known in humans. With a net rate of fluorodeoxyglucose phosphorylation close to 0. 025 ml g-I min -I, a blood glucose concentration of 5 mM, and a whole-brain glucose consumption close to 0.25 fLmol g-I min -I, the lumped constant must be close to 0. 50.
The model-independent determination of the whole-brain lumped constant is only half of the problem, however. The strength of the deoxyglu cose method is its ability to highlight differences between brain regions. Thus, it is the regional vari ation of the lumped constant that matters . The use of the whole-brain lumped constant is questionable because it involves a circular argument: In theory, it is possible that regional differences represent dif fe rences between the lumped constants rather than between glucose phosphorylation.
The crux of the current regional estimation of the lumped constant is the measurement of brain glu cose. In the final analysis, we can reduce the op-erational equation of the method to a product of k9 and M¥, where k9 , the phosphorylation constan£ , is calculated from k� and Meg, the brain glucose content , from the distribution of methylglucose. Since the product is well known fo r whole brain, the most important unknown remains the brain glu cose. If brain glucose were known in humans, its relation to methylglucose distribution could be es tablished and the k9lk9 ratio confirmed.
Although this analysis may appear to render the deoxyglucose method dependent on an unknown entity, i.e. , the human brain glucose content , we emphasize that it is the regional variability of the lumped constant that matters , not its whole-brain average.
A similar conclusion was reached by Phelps et al . (1983) . Proceeding from Eq. 6, they argued that the ratios K9/K9. and k9/k9 are relatively constant and depend chiefly on the blood flow. In that case, the lumped constant must depend primarily on the k�/ k9 ratio, which in turn depends on the brain glucose content (since k� is rather insensitive to changes of brain glucose, whereas k9 is very sensitive) . From estimates of the rate constants, it is possible to es timate the deviation of the lumped constant from a global average , called a "stability fa ctor" by Phelps et al . This approach may suffer from the unknown magnitude of the transfer constants for glucose in humans.
Transfer constants
The transfer constants K9 , k9 , k�, and often k� have played a role in the discussions of the deoxy glucose method. In the present study, they were calculated from the net rate of fluorodeoxyglucose accumulation and the distribution of methylglucose and fluorodeoxyglucose. The values reported here for the transfer constants differ somewhat from those published previously (Heiss et aI ., 1984) . This discrepancy may largely be explained by differ ences among groups of subjects as well as on meth odological grounds, as the previous data were de rived from individual fits to the fluorodeoxyglucose uptake curves recorded in healthy volunteers who generally had somewhat higher metabolic rates than the patients comprising the present group . While the values of k� were very similar, the averages of K9 and , most of all, of k9 were higher in this study because the model prescribes a constant ratio close to 0. 5 ml g-l between K9 and k9.
It is difficult to arrive at accurate, independent estimates of the transfer constant s under non steady-state conditions, nor can they be estimated in the steady state from deoxyglucose alone (meth ylglucose is also required) . Therefore , the present approach was designed to eliminate the need to know the magnitude of the transfer constants.
The regression procedures yielding regional es timates of the transfer constants (the "dynamic" approach) really yield estimates of combinations of transfer constants, i.e., the net rate of deoxyglucose accumulation [K9 k�/(k9 + k�)] and the steady state volume of distribution of deoxyglucose K9/(k9 + k�) , the term necessary to calculate the contri bution of unphosphorylated deoxyglucose.
Pathological tissue
As expected, the infarcted regions showed great variability with respect to glucose content and lumped constant , as well as to the glucose phos phorylation calculated with the aid of these vari ables . The study confirmed that lumped constants could be estimated under these circumstances . In addition, the study tentatively identified two infarct types, a transportlflow-limited type and a phos phorylation-limited type. However, it is not clear whether the latter is characterized by a smaller number of energy-consuming cells or by a specific limitation of glycolysis. Hawkins et al . (1981) al so studied stroke patients and divided them into two groups of severe versus moderate ischemia on the basis of an index of met abolic depression in the ischemic (or rather post ischemic) regions. The "stability" of the lumped constant was assessed by considering the change of the phosphorylation/dephosphorylation ratio for glucose (i.e. , the k9/k� ratio) . The authors con cluded that the lumped constant had not deviated significantly from the normal range in either of the two groups, although it was perhaps more "un stable" in the severely ischemic group . In the con sideration of the lumped constant stability, the au thors specifically ignored any change of the "dis tribution" ratio (Ll in the present report) because they expected all ratios to remain constant . It is clear from the present article that changes of the distribution ratio influence the lumped constant more than other factors . This may explain why Hawkins et al . (1981) were unable, according to their analysis, to identify any postischemic regions in which changes of the lumped constant were likely to have occurred .
